787 related articles for article (PubMed ID: 23416119)
41. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
42. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.
Vinores SA; Küchle M; Derevjanik NL; Henderer JD; Mahlow J; Green WR; Campochiaro PA
Histol Histopathol; 1995 Oct; 10(4):913-23. PubMed ID: 8574012
[TBL] [Abstract][Full Text] [Related]
43. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
[TBL] [Abstract][Full Text] [Related]
44. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
45. Blood-retinal barrier glycerol permeability in diabetic macular edema and healthy eyes: estimations from macular volume changes after peroral glycerol.
Thornit DN; Vinten CM; Sander B; Lund-Andersen H; la Cour M
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2827-34. PubMed ID: 20042642
[TBL] [Abstract][Full Text] [Related]
46. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
47. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process.
Ehrlich R; Harris A; Ciulla TA; Kheradiya N; Winston DM; Wirostko B
Acta Ophthalmol; 2010 May; 88(3):279-91. PubMed ID: 20222885
[TBL] [Abstract][Full Text] [Related]
48. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
[TBL] [Abstract][Full Text] [Related]
49. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
50. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy.
Zhang T; Mei X; Ouyang H; Lu B; Yu Z; Wang Z; Ji L
J Nutr Biochem; 2019 Mar; 65():1-14. PubMed ID: 30597356
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
[TBL] [Abstract][Full Text] [Related]
52. Rat model for anterior segment intraocular surgery induced blood-retinal barrier breakdown.
Xie MS; Xu GX; Huang Y
Ophthalmologica; 2008; 222(1):42-7. PubMed ID: 18097180
[TBL] [Abstract][Full Text] [Related]
53. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
[TBL] [Abstract][Full Text] [Related]
54. New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography.
Byeon SH; Chu YK; Hong YT; Kim M; Kang HM; Kwon OW
Retina; 2012 Jun; 32(6):1087-99. PubMed ID: 22481473
[TBL] [Abstract][Full Text] [Related]
55. Origins and consequences of hyperosmolar stress in retinal pigmented epithelial cells.
Willermain F; Libert S; Motulsky E; Salik D; Caspers L; Perret J; Delporte C
Front Physiol; 2014; 5():199. PubMed ID: 24910616
[TBL] [Abstract][Full Text] [Related]
56. The blood-retinal barriers.
Cunha-Vaz JG
Doc Ophthalmol; 1976 Oct; 41(2):287-327. PubMed ID: 1009819
[TBL] [Abstract][Full Text] [Related]
57. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
58. Regulation of retinal blood flow in health and disease.
Pournaras CJ; Rungger-Brändle E; Riva CE; Hardarson SH; Stefansson E
Prog Retin Eye Res; 2008 May; 27(3):284-330. PubMed ID: 18448380
[TBL] [Abstract][Full Text] [Related]
59. Nicotine promotes blood retinal barrier damage in a model of human diabetic macular edema.
Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
Toxicol In Vitro; 2017 Oct; 44():182-189. PubMed ID: 28689815
[TBL] [Abstract][Full Text] [Related]
60. Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference.
Arredondo Zamarripa D; Noguez Imm R; Bautista Cortés AM; Vázquez Ruíz O; Bernardini M; Fiorio Pla A; Gkika D; Prevarskaya N; López-Casillas F; Liedtke W; Clapp C; Thébault S
Sci Rep; 2017 Oct; 7(1):13094. PubMed ID: 29026201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
